Home Cart Sign in  
Chemical Structure| 2280037-51-4 Chemical Structure| 2280037-51-4

Structure of Bobcat339
CAS No.: 2280037-51-4

Chemical Structure| 2280037-51-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bobcat339 is a potent and selective cytosine-based TET enzyme inhibitor, with IC50 values of 33 μM and 73 μM for TET1 and TET2, respectively. It is valuable in epigenetics research and serves as a starting point for developing new therapeutics targeting DNA methylation and gene transcription.

Synonyms: BC339

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bobcat339

CAS No. :2280037-51-4
Formula : C16H12ClN3O
M.W : 297.74
SMILES Code : ClC(C(N)=N1)=CN(C2=CC(C3=CC=CC=C3)=CC=C2)C1=O
Synonyms :
BC339
MDL No. :MFCD32644557
InChI Key :QMGYGOOYCNTEQO-UHFFFAOYSA-N
Pubchem ID :138319673

Safety of Bobcat339

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Bobcat339

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PCBC-CMs 150 µM 14 days AA significantly increased MLC2v expression in PCBC-CMs and promoted hiPSC-CMs maturation through DNA demethylation. Theranostics. 2023 Jul 3;13(11):3872-3896.
DP3-CMs 150 µM 14 days AA significantly increased MLC2v expression in DP3-CMs and promoted hiPSC-CMs maturation through DNA demethylation. Theranostics. 2023 Jul 3;13(11):3872-3896.
MLC2v-CMs 150 µM 14 days AA significantly increased MLC2v expression in MLC2v-CMs and promoted hiPSC-CMs maturation through DNA demethylation. Theranostics. 2023 Jul 3;13(11):3872-3896.
RA induced atrial-like PCBC-CMs 150 µM 14 days AA significantly increased MLC2v expression in RA induced atrial-like PCBC-CMs and promoted hiPSC-CMs maturation through DNA demethylation. Theranostics. 2023 Jul 3;13(11):3872-3896.
Swine Scattered Tubular-like Cells (STCs) 10 µM 24 hours Bobcat339 decreased the expression of inflammatory genes in RAS-STCs and reduced the protein expression of pro-inflammatory cytokines TNF-α, IL-6, and IF-γ. Clin Sci (Lond). 2023 Aug 31;137(16):1265-1283.
HT-22 cells 10 µM 24 hours To evaluate the ability of Bobcat339 to reduce 5hmC levels in live cells, results showed that Bobcat339 significantly reduced global 5hmC levels ACS Med Chem Lett. 2019 Jan 31;10(2):180-185.
KGN cells 40 nM 24 hours To explore the reversal effect of Bobcat339 on Fer-1 in Hcy-induced KGN cell injury Mol Med Rep. 2022 Apr;25(4):130.
Porcine oocytes 100 µM, 200 µM, 400 µM 24 hours, 36 hours, 44 hours Bobcat339 treatment significantly reduced the first polar body extrusion rate and triggered early apoptosis. Int J Mol Sci. 2023 Aug 5;24(15):12455.
MCF-7 33 µM and 75 µM 24, 48, and 72 hours Bobcat339 was able to revert IL-1β-induced proliferation of MCF-7 cells and inhibit IL-1β-induced accelerated wound closure. Int J Mol Sci. 2022 Dec 6;23(23):15422.
Porcine oocytes 200 µM 44 hours Bobcat339 treatment caused abnormal spindle architecture and chromosome alignment. Int J Mol Sci. 2023 Aug 5;24(15):12455.
SH-SY5Y cells 10 µM 48 hours Bobcat339 stimulated the expression of AGRP, NPY, and SLC32A1 in a TET3-dependent manner Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2300015120.
Human monocyte-derived macrophages (MDMs) 10 µM 48 hours Bobcat339 induces TET3 degradation, leading to apoptosis in TET3-overexpressing macrophages. J Clin Invest. 2024 Nov 1;134(21):e181839.
Mouse RAW 264.7 macrophages 10 µM 48 hours Bobcat339 induces TET3 degradation, leading to apoptosis in TET3-overexpressing macrophages. J Clin Invest. 2024 Nov 1;134(21):e181839.
Huh-7 cells 40 µM 48 hours Bobcat339 significantly reduced the expression of DNA repair-related genes Cell Mol Life Sci. 2024 Jul 5;81(1):284.
Huh-7 cells 80 µM 48 hours Bobcat339 significantly reduced the expression of DNA repair-related genes Cell Mol Life Sci. 2024 Jul 5;81(1):284.
Hep3B cells 50 µM 48 hours To assess the effect of Bobcat339 on 5hmC levels in Hep3B cells, results showed that Cu(II)-contaminated MedKoo-Bobcat339 significantly reduced 5hmC levels, while Sigma-Bobcat339 did not show a reduction in 5hmC levels. ACS Med Chem Lett. 2022 Apr 21;13(5):792-798.
GT1-7 cells 10 µM 6 hours Bobcat339 decreased TET3 protein levels without affecting its mRNA expression Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2300015120.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Activity-based anorexia (ABA) model Intraperitoneal injection 2.5 mg/kg Once a week for 3 weeks Bobcat339 increased food intake, decreased compulsive running, and diminished lethality in the ABA model by reducing TET3 protein expression in AgRP neurons Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2300015120.
BALB/c Nude mice HCC model Intraperitoneal injection 2.5 mg/kg Every 2 days for 3 weeks Combined treatment with Bobcat339 and sorafenib almost completely halted HCC growth Cell Mol Life Sci. 2024 Jul 5;81(1):284.
Pig Parthenogenetic embryos In vitro culture 25 µM, 50 µM, 100 µM Cultured until day 6 Bobcat339 treatment significantly reduced the blastocyst rate of parthenogenetic embryos and arrested embryo growth at the 4-cell stage. Int J Mol Sci. 2023 Aug 5;24(15):12455.
Mice Endometriosis model Intraperitoneal injection 3 mg/kg Once a week for 6 weeks Bobcat339 significantly reduced the volume of endometriosis lesions and decreased the number of TET3-overexpressing macrophages in the lesions by degrading TET3. J Clin Invest. 2024 Nov 1;134(21):e181839.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.36mL

0.67mL

0.34mL

16.79mL

3.36mL

1.68mL

33.59mL

6.72mL

3.36mL

References

 

Historical Records

Categories